Methyl tertiary -butyl ether ( MTBE ) is an oxygenated compound added to gasoline to improve air quality as part of the US Federal Clean Air Act. Due to the increasing and widespread use of MTBE and suspected health effects, a controlled, short -term MTBE inhalation exposure kinetics study was conducted using breath and blood analyses to evaluate the metabolic kinetics of MTBE and its metabolite, tertiary -butyl alcohol ( TBA ) , in the human body. In order to simulate common exposure situations such as gasoline pumping, subjects were exposed to vapors from MTBE in gasoline rather than pure MTBE. Six subjects ( three females, three males ) were exposed to 1.7 ppm of MTBE generated by vaporizing 15 LV% MTBE gasoline mixture for 15 min. The mean percentage of MTBE absorbed was 65.8 5.6% following exposures to MTBE. The mean accumulated percentages expired through inhalation for 1 and 8 h after exposure for all subjects were 40.1% and 69.4%, respectively. The three elimination half -lives of the triphasic exponential breath decay curves for the first compartment was 1 ± 4 min, for the second compartment 9 ± 53 min, and for the third compartment 2 ± 8 h. The half -lives data set for the breath second and blood first compartments suggested that the second breath compartment rather than the first breath compartment is associated with a blood compartment. Possible locations for the very short breath half -life observed are in the lungs or mucous membranes. The third compartment calculated for the blood data represent the vessel poor tissues or adipose tissues. A strong correlation between blood MTBE and breath MTBE was found with mean blood -to -breath ratio of 23.5. The peak blood TBA levels occurred after the MTBE peak concentration and reached the highest levels around 2 ± 4 h after exposures. Following the exposures, immediate increases in MTBE urinary excretion rates were observed with lags in the TBA excretion rate. The TBA concentrations reached their highest levels around 6 ± 8 h, and then gradually returned to background levels around 20 h after exposure. Approximately 0.7 ± 1.5% of the inhaled MTBE dose was excreted as unchange urinary MTBE, and 1 ± 3% was excreted as unconjugated urinary TBA within 24 h after exposure.
Introduction
The 1990 Clean Air Act Amendments ( CAAA ) require regions in the US that are in noncompliance with National Ambient Air Quality Standards (NAAQS ) for CO to use oxygenated fuels during the winter months. Methyl tertiary -butyl ether (MTBE ) is the most widely used oxygenated additive in this program because of its high octane number, favorable transfer and blending characteristics, ease of production and low costs.
In several areas of the US, residents have complained of a variety of health effects from exposure to emissions from MTBE -blended gasoline: headaches, dizziness, nausea, sore eyes and respiratory irritation. The human health effects of MTBE are still not clear. Experimental studies in rats and mice indicate that MTBE is carcinogenic for some target organs following oral and inhalation exposure. The primary metabolites of MTBE, tertiary-butyl alcohol (TBA ) and formaldehyde, are also carcinogenic in animals.
For the general population, the activities that lead to the highest potential exposure include motor vehicle refueling, commuting to work in an automobile, and driving an automobile as part of employment (Lioy et al., 1994 ) . The average MTBE concentration of personal breathing zone samples from service station attendants in Phoenix, Arizona, where MTBE content averaged 12.5± 13 LV%, was 0.3 ppm. At the two stations equipped with Stage II vapor-recovery systems in Los Angeles, the average personal breathing zone MTBE levels of attendants was 0.09 ppm (Hartle, 1993 ) . Data from a refueling ( self -service, non -Stage II vapor recovery ) study, with gasoline containing 15% MTBE by volume, indicated that the highest breathing zone air concentration of MTBE was 0.11 ppm, during refueling ( Lindstrom and Pleil, 1996 ) . However, another study ( Lioy et al., 1994 ) documented that during a 5 -min refueling (self -service ), the mean MTBE concentrations for personal breathing zone samples are higher than 0.3 ppm, with a maximum value of 4.1 ppm. Vayghani and Weisel ( 1999 ) reported that the upper MTBE level in automobile cabins while fueling exceeded 1 ppm in New Jersey. The highest incabin concentrations of MTBE occurred in a series of cars sampled on a warm, calm winter day. The in -cabin concentrations were typically higher when the car window was opened during refueling.
Levels of MTBE and its metabolite TBA in biological samples can be directly measured and provide quantitative estimates of absorption and retention of MTBE in the human body. The uptake and elimination of MTBE following inhalation exposure under either controlled conditions or occupational settings have been studied Prah et al., 1995; Cain et al., 1996; Lindstrom and Pleil, 1996; Buckley et al., 1997; Saarinen et al., 1998; Nihle Ân et al., 1998a ,b, 1999 , Amberg et al., 1999 . Alveolar breath measurement is one method adopted to evaluate the pharmacokinetics of MTBE. Blood MTBE and TBA levels provide information on metabolism and disposition following exposure. Since urine collection is noninvasive and sufficient volume of sample is attainable, the measurement of MTBE and TBA in urine is a suitable way to understand the excretion of MTBE. However, most of the controlled exposure studies have been conducted at exposure scenarios of higher part per million concentration or at longer exposures than typically occur in the environment to the general population. Furthermore, most of the studies have used pure MTBE rather than MTBE in gasoline, which is the common mixture that people are exposed to. The major purpose of this study is to verify the toxicokinetic patterns of MTBE metabolism and excretion following controlled short -term exposure at low ppm concentration using MTBE in gasoline.
Materials and methods

Experimental Design
Six healthy subjects participated in this study (three females, three males ) . Medical history evaluation and physical examination were conducted for each subject. They received spirometry testing, EKG, urine testing and blood testing including blood counts, chemistries and immunologic marker. Subjects with any of the following medical conditions were excluded: neurologic disease or brain injury, significant exposure to other neurotoxicants, chronic fatigue syndrome or multiple chemical sensitivity, stroke or cardiovascular disease, serious major psychiatric conditions including psychoses, manic depression, alcoholism or drug abuse. Also excluded were smokers, and pregnant or lactating women. Informed consent was obtained from each subject.
Two subjects were exposed simultaneously with a time interval of at least one week between sequential exposures. Urine void samples from the first morning urine of the exposure day until the following morning, including a sample 5 ±10 min before exposure, were collected. The breath and blood background samples of the subjects were collected 5 ±10 min before they entered the facility. The exposure scenario was conducted in a Controlled Environmental Facility ( CEF ) . The protocol setting MTBE level of 1.7 ppm was based on exposure that occurs during gasoline refueling. The vapor was generated by vaporizing 15 LV% MTBE gasoline mixture. The temperature and relative humidity were set at 708F and 40%, respectively. The subjects entered the facility after the MTBE concentration reached the desired level. Air and breath samples were taken concurrently during the exposure at 4 -min time intervals. The postexposure biological samples were collected in a room with no known MTBE sources at the times indicated in Table 1 .
Controlled Environmental Facility (CEF )
The Controlled Environment Facility (CEF ) at the Environmental and Occupational Health Sciences Institute (EOHSI ) is a large walk -in room with stainless steel walls and a volume of 887 ft 3 (13.5Â9Â7.3 ft ) . The temperature and relative humidity of the CEF were set at 218C and 40% in this study. A constant concentration of MTBE was maintained by continuously heating a predetermined amount of MTBE mixed in gasoline in a heated vessel and transferring the vapors emitted into the air supply. MTBE concentrations were continuously monitored using an onsite GC /FID (Model 3700, Varian ) and a total hydrocarbon analyzer (Model 23 -500, Gow -Mac Instrument ) . The instrumentation that monitors the total hydrocarbon levels is interfaced to the instrumentation that injects the gasoline mixtures to provide a constant overall total hydrocarbon air concentration within the CEF.
Analytical Methods
Air samples within the CEF were collected on adsorbent traps consisting of stainless steel tubes (Perkin -Elmer, 0.5 cm idÂ8.8 cm ) packed with 0.6 g Carboxen 1 569 ( Supelco, PA ). Carboxen 569 has excellent adsorption and desorption properties for volatile organic compounds (VOCs) including MTBE and TBA, as well as low water vapor retention making it suitable for analyzing breath, blood and urine samples by the purge-and-trap method. Newly packed traps were conditioned in an oven at 3408C for 6 h with zero grade nitrogen ( Air Products and Chemicals, PA ) . Sampling traps were reconditioned by continuous flushing with zero grade nitrogen while being heated at 3408C for 4 h. Constant flow pumps (Model 224 -43XR, SKC ) were used for the breath sampling while personal sampling pumps (Model P4LA, Du Pont ) were used for the air sampling. The flow rates of the pumps were calibrated before and after each sampling run using an electronic bubble flow meter (Buck Calibrator, A.P. Buck ) with a sampling trap in line.
Alveolar breath samples were collected by the method modified from Raymer et al. ( 1990 ) . The alveolar breath The tidal volumes are predicted using Radford nomogram for a breathing frequency of 15 breaths / min ( Comroe, 1974 ) . b Tidal volumeÂ15 breaths / minÂ0.67. sampling train includes a mouthpiece, a one-way breathing valve (Laerdal Valve IV ) , a Teflon connector, polyethylene tubing (1.27 cm I.D.Â7.6 m ), an adsorbent trap, and a personal sampling pump. The subject breathed through the mouthpiece and valve while wearing a noseclip. Exhaled air passed through the valve into the connector and tubing. One end of the trap was connected to the side port of the Teflon connector and the other end was connected to the personal sampling pump. The sampling flow rate was set to approximately 1.5 l/ min, and the sampling times were from 1 to 3 min. All breath samples were collected while subjects were at rest. The breathing -zone ambient air samples were collected while breath samples were being taken during the exposure. The air samples were collected close to the inlet of the breathing valve using the adsorbent traps described above. The air-sampling flow rate was set to approximately 150 cc /min, and the sampling durations were the same as the simultaneously collected breath sample. One integrated breathing -zone air sample was collected in the CEF for the entire exposure period at a sampling flow rate of 30 cc /min.
Urine voids were collected in individual 450-ml multipurpose plastic containers (Fisher Scientific ). The urine samples were stored in a cooler, which contained prefrozen coolant (blue ice ), until they were retrieved from the subject. The urine was transferred into glass vials, which were immediately sealed with Teflon -faced silicon septa when they were received in the laboratory and stored at 48C until analyzed ( Lee and Weisel, 1998 ) .
The blood samples were collected through a Jelco* winged I.V. catheter ( Johnson & Johnson, NJ ) into a 10 -ml Vacutainer 1 with 20 mg potassium oxalate and 25 mg sodium fluoride ( Becton Dickinson, NJ ) and stored at 48C until analysis. A 10-ml aliquot was transferred to a glass bubbling tube ( 250 ml ) using a glass syringe, and diluted with 100 ml disodium ±EDTA water solution ( 10 mg /ml ) before purging. One drop of antifoam solution was added to prevent foaming. The glass bubbling tube was then connected to a purge-andtrap system. A purging chamber of 250 -ml glass bubbling tube was immersed in a water bath whose temperature was thermostatically controlled at 858C. An air-washing bottle placed between the purging chamber and trap was immersed in an ice bath to reduce the humidity levels in the exiting purge gas while it was heated. The blood sample was purged with zero grade helium at 140 ml /min for 15 min. The thermal desorption and GC /MS conditions were the same as the values used for the urine samples ( Lee and Weisel, 1998 ) . Air samples collected with the adsorbent traps were compared to air samples simultaneously analyzed using an on -site GC with a flame ionization detector. The coefficient of variance between the paired samples was 0.12. Duplicate blood samples were collected and analyzed using the procedures as described here and by the Center for Disease Control and Prevention during the same time period ( Fiedler et al., 2000 ) . No statistical differences were found between paired blood samples and the coefficient of variances across the two laboratories were 0.5 for MTBE and 0.4 for TBA.
Results
Participant Characteristics
The general characteristics of each subject are given in Table 2 . The tidal volume of each subject was predicted using the Radford nomogram with a breathing frequency of 15 breaths /min (Comroe, 1974 ) . The ventilation rate is the product of the tidal volume and breathing frequency ( breaths /min ). The alveolar ventilation rate was assumed to be 67% of the ventilation rate.
MTBE Air Concentrations Inside CEF
The breathing -zone air samples were taken during MTBE exposure. The results (Table 3) show that the MTBE air concentrations inside the CEF ranged from 5510 g/m 3 (1.5 ppm ) to 6480 g/m 3 (1.8 ppm ) during the exposures. The average air MTBE concentration for six runs was 5870 g/m 3 ( 1.6 ppm ) . The results indicated that the MTBE levels were maintained consistently within 10% of protocol setting value 1.7 ppm during the different runs.
MTBE Concentration in the Exhaled Breath During Exposure
One pre -exposure breath sample was taken from each subject before entering the CEF. The background preexposure MTBE breath levels were lower than the breath concentrations measured during or after the exposure (Table  3 ) . One representative example is shown in Figure 1 ( S -1 ).
Most of the pre -exposure breath MTBE levels were less than the detection limit, of 1.2 g/m 3 . Three or four breath samples were taken for each subject during the 15-min exposure. The exposure resulted in an increase in the breath concentration. The mean breath MTBE concentrations for 2, 
Internal Dose
The MTBE internal dose to the subject was calculated from the area between the inhaled air concentration curve ( AUC A ) and the alveolar breath concentration curve ( AUC B ) during the exposure period multiplied by the subject's average alveolar ventilation rate ( Table 4 ) . The mean MTBE internal dose was 160 50 g for all subjects for the 15 -min MTBE exposure. The calculated internal doses ( mean: 197 40.7 g ) for male subjects were statistically significantly higher (P < 0.05) than that of the female subjects ( mean: 122 18.2 g ). The higher ventilation rate of the male subjects is the probable reason.
Elimination of MTBE After Exposure
The elimination patterns for the six subjects were similar. One example (S -1 ) is shown in Figure 2 . The breath MTBE levels declined quickly following the 15-min exposure. All postexposure breath concentrations dropped more than 50% in 10 min. Breath levels of TBA, the metabolite of MTBE, never exceeded its detection limit of 1.5 g/m 3 .
Empirical Modeling of Postexposure MTBE Breath Concentrations A triphasic decay model that was developed by Wallace et al. ( 1993 ) was used for modeling MTBE concentrations in the postexposure breaths.
where C alv =breath concentration; C 1 , C 2 , C 3 = constants that represent the contribution from unknown compartments; k 1 , k 2 , k 3 =rate constant of first, second and third exponential, respectively; t= elapsed time from the end of exposure.The calculated equations fit the observations quite well ( R 2 > 0.995 in all cases ) . The elimination half -lives of the each compartment, t 1 / 2 was calculated from: t 1=2;i ln 2=k i 0:693=k i 2 where t 1 / 2 =elimination half lives of the ith compartment; k i = rate constant of the ith compartment; The curve -fitting process was conducted to calculate coefficients using Sigmaplot (Jandel Scientific ). The calculated values of the six coefficients and R 2 values for the decay equations are shown in Table 5 . The three elimination half -lives of the triphasic exponential decay for the experiments are shown in Table 6 . The overall mean half -lives for the first, second, and third compartments were 2.0, 25.9 and 300 min, respectively. No differences between mean half -lives for the three compartments were observed between female and male subjects.
Excretion Amounts Through Respiration After Exposures
The amount of MTBE eliminated through respiration was calculated as the product of the postexposure AUC B and alveolar ventilation rate. The AUC B was estimated by integrating the postexposure empirical equation to the given time. Since the exposure concentrations were constant the durations were all equivalent. The percentage of dose expired at specific time periods after exposure can be compared. Difference can be related to difference in metabolic rates or storage capacities in the various body components of the subjects. About 21.9% of the MTBE internal dose was expired through inhalation within 10 min of the end of the exposure. The mean accumulated percentages expired for 1 and 8 h after exposure for all subjects were 40.1% and 69.4%, respectively (Table 7 ) .
Fraction of Air Concentration Exhaled at Steady State
To examine the overall metabolic rate and storage capacity of individuals the fraction exhaled at pseudo steady state can be calculated. During exposures, the concentration of MTBE in alveolar breath and the fraction of air concentration, f, can be written as (following Buckley et al., 1997 ) :
where f=the fraction of air concentration exhaled at steady state; C air = air concentration; a i =C i H / fC air ( C i H : the capacity of the compartment at steady state ); i = intrinsic residence time ( 1 = t 1 / 2 / ln 2 ). To estimate the fraction f exhaled at steady state, we can solve the above equation by substituting the exposure period of 15 min for t. The mean value of calculated f for each subject is shown in Table 8 .
Blood MTBE and TBA Concentrations Following Exposures
Pre -and postexposure venous blood MTBE and TBA levels were measured. An example of the uptake and decay 
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Toxicokinetics of human exposure to MTBE of MTBE and of TBA in blood are shown in Figure 3 (S -1 ). The mean background MTBE and TBA levels for all subjects were 0.47 0.25 and 0.68 0.6 g/l, respectively. Immediately following the controlled exposures the blood MTBE reached its highest level and then declined to background level in most of the cases. The increase in TBA levels lagged that of MTBE, reaching its highest levels (5 ± 10 g /l ) around 2 to 4 h after exposure before declining slowly. TBA did not always reach background levels within 24 h after exposure, the time the last sample was collected.
The Relationship Between Blood and Breath Levels
It is almost impossible to collect breath and blood samples simultaneously because of the difficulties of drawing blood. Therefore, in this study the breath and blood pair samples were collected as close together as possible, usually within 1 min of each other. For each individual experiment, a strong correlation between blood MTBE and breath MTBE levels was observed ( R 2 > 0.7 ). The average venous MTBE blood -to -breath ratio was estimated from the slopes of the linear regression equations ( Figure 4 ) . A wide range of the blood / breath ratios was observed (mean: 23.5, range: 13 to 36 ).
Urinary Excretions of MTBE and TBA Following Exposures
The amount of MTBE and TBA in each urine void was calculated by multiplying MTBE and TBA concentrations by the urine volume. The excretion rates (nanograms per minute ) of MTBE and TBA between two consecutive urine voids were calculated by dividing the amounts (nanograms) of the MTBE and TBA in a urine void by the time interval ( minutes ) between urine voids.
One example of the urinary excretion of MTBE and unconjugated TBA following exposures are shown in Figure 5 (S -1) . The background excretion rates were low (MTBE: 0.32 0.32 ng/min, TBA: 0.50 0.41 ng/ min ) for all subjects. Following the exposure, the MTBE excretion rate increased immediately whereas the TBA excretion rate increase had a time lag of several hours. The MTBE declined to background around 10 to 15 h after exposure. The TBA urinary excretion rate reached its highest value 3 to 11 h after exposure. Using the calculated internal dose, the cumulative amount and percent of absorbed dose (within 24 h of exposure ) of MTBE and unconjugated TBA excreted in the urine were estimated ( Table 9 ). The mean cumulative amount of MTBE and of unconjugated TBA excreted in urine were 1.35 and 2.27 g, respectively, which represented 0.95% and 2.8% of the absorbed doses, respectively.
Discussions
Background MTBE and TBA Levels The current study's pre -exposure MTBE breath levels are associated with background environmental MTBE exposure. The mean MTBE level for pre -exposure breath samples was 2.9 4.3 g/m 3 . The pre -exposure breath measurements made by Lindstrom and Pleil (1996 ) ranged between 7.8 and 5.6 g/m 3 . The study conducted by Buckley et al. ( 1997 ) measured background breath levels of MTBE for one female and one male subject of 3.6 and 12.6 g/m 3 , respectively. In the current study, the TBA was not detected in any of the pre -and postexposure breath samples. TBA is rarely measurable in exhaled breath due to the hydrogen bonding between TBA and water and high blood ± air partition coefficient of 462 . This finding is consistent with the study of Buckley et al.
The mean pre -exposure blood concentrations of MTBE ( 0.47 0.25 g/l ) and TBA (0.68 0.6 g /l ) were similar to studies conducted in Alaska (Moolenaar et al., 1994 ) and Connecticut (White et al., 1995 ) . In Alaska, during the oxygenated fuel program, the median postshift blood concentration of MTBE in the 18 workers was 1.8 g/l ( range, 0.2 ±37.0 ) . After the program was suspended, the median postshift blood concentration in the 28 workers was 0.24 g /l ( range: 0.05 ±1.44 g /l) . In Connecticut, the median blood levels of MTBE among 21 car-repair workers and 14 commuters were 1.73 g /l ( range, 0.17 ± 36.7 g/l) and 0.11 g /l (range, <0.05 ± 2.6 g /l) , respectively; and the mean TBA blood levels for workers and commuters were 15 g/ l ( range, 2 ±40 g/l) and 2 g/l (range, 0.4± 8 g/l ), respectively. The pre -exposure MTBE and TBA levels in the current study, all of whom either drove or took public transportation to EOHSI shortly before the samples were collected, were consistent with the levels of the commuters in Connecticut.
Internal Dose A``sawtooth'' pattern was observed in the breath concentration curves during some exposures (S -1, M -1, 2, J-2, F -1 ). Hong et al. (1997) found olfactory mucosa has a high metabolic activity for MTBE in rats. In that study, the metabolic activity of the olfactory mucosa was 46 times higher than that of the liver in rats. A high olfactory mucosa metabolic activity could cause a portion of the inhaled MTBE to be metabolized or retained in the upper airway before entering the human lung for further mass transfer, distribution and metabolism. Water solubility is probably the most important chemical property affecting the mass transfer of organic compounds between an aqueous and gas phase. MTBE is more water-soluble than other compounds present in gasoline so MTBE tends to partition strongly from the gas phase into water. MTBE's water solubility may result in some of the inhaled MTBE being absorbed in the moisture rich environment of the upper and lower respiratory tract. The role of the upper airway (nose, mouth, pharynx, larynx, trachea, bronchi and bronchioles ) in the toxicity, uptake and metabolism of MTBE should be considered for the further studies.
Fraction of Air Concentration Exhaled and Amount of MTBE Absorbed During Exposures
The overall mean of the fraction of air concentration exhaled during exposures for the six subjects was 0.33 0.06%. Buckley et al. ( 1997 ) exposed two subjects at 1.39 ppm for 1 h, the f value at steady state for female and male subject were 0.6 and 0.46, respectively. Johanson et al. (1995 ) measured relative uptake rates for 10 males ranging from 32% to 42% (5, 25 and 50 ppm for 2 h ) . As the dose increased, there was a shift in uptake rate to lower percentage being absorbed and more being excreted in expired air. For a short -term, low -level exposure condition, the relative MTBE uptake percentage was higher than that of the long -term, higher level exposure. The amount of MTBE absorbed (internal dose ) during exposures is the product of the subject's alveolar ventilation rate and the difference between AUC A and AUC B . In the current study, the alveolar ventilation rate was not measured directly but can be determined from the tidal volume, the breathing frequency and the dead space. Many factors can affect the alveolar ventilation rate, including: age, body weight, gender, and status of exercise. The tidal volumes in the current study were estimated from empirical estimation ( Comroe, 1974 ) . It is recommended that future studies directly measure ventilation rate because it is important for the estimation of MTBE internal dose.
Elimination of MTBE Through Respiration
The range of the half lives for the first compartment were within 3 min; for the second compartment were 10 to 53 min; and for the third compartment were 2 to 8 h. ( Table 6 ). These results are generally consist with previously reported values ( Table 10 ) . Raymer et al. (1992 ) indicated that if the calculated third half -life is unrealistically high, the third compartment may contain data from a fourth compartment. The estimated third half -life in the current study was shorter than 10 h in all cases. Therefore, for the short -term low -level MTBE exposure used, the three -compartment model to evaluate the elimination of MTBE through respiration is appropriate. Possible reasons for the relatively wide range in half -life values include exposure to other MTBE sources after exposure and differences in the metabolic rates or storage capabilities in the body among the subjects.
Blood MTBE and TBA Levels Following Exposures
The blood MTBE concentration reached peak levels at the end of exposure with a range from 4 to 10 ng /ml. These results are generally consistent with other studies. Peak MTBE levels of 15 and 8.7 ng /ml for female and male subjects were observed by Buckley et al. ( 1997 ) for two subjects exposed to 1.39 ppm for 1 h. Johanson et al. ( 1995 ) exposed 10 male subjects to 5, 25, and 50 ppm for 2 h, and much higher peak MTBE levels were found as 114, 572, and 1,144 ng/ ml, respectively. The linear relationship between peak MTBE level and dose ( concentrationÂdura-duration ) is consistent from different studies. The range of the mean half -lives for the three compartments in the current study were 18 ± 40 min, 57 ±74 min and 14± 33 h, similar to the results of Johanson et al. (1995 ) .
A strong correlation between alveolar breath MTBE levels and blood MTBE was found. The uptake and disposition of MTBE depends on the partitioning between blood and air and between blood and tissues. Thus, partition coefficients are important factors in controlling the MTBE kinetics in the human body. The average blood -to -breath ratios for female and male subjects were calculated to be 23.4 and 23.6, respectively, using a linear regression analysis. Nihle Ân et al. (1995 ) reported a blood / air partition coefficient of 17.7 derived from an in vitro study, and Buckley et al. ( 1997 ) estimated the ratio as 18. The bloodto -breath partition coefficient for MTBE suggests an efficient uptake of MTBE from inhaled air to blood. The blood / air partition coefficient of TBA had been reported as 462 , indicating higher partitioning of TBA in blood compared to MTBE. Due to the high blood / air partition coefficient, TBA is rarely measured in the exhaled air following a low -level MTBE exposure.
The half -lives of TBA in the blood for a single female and single male subject were 10.5 and 8.0 h, respectively. Following a 2 -h exposure to MTBE, the half -lives of TBA measurements made by Johanson et al. ( 1995 ) were 10.1 h for 25 ppm, and 10.2 h for 50 ppm. Buckley et al. estimated the half -lives of TBA in blood for the male subject being 2 ±3 h, but for the female subject, the half -life estimated was between 2.5 and 5 days. In the current study, the mean half -life of blood TBA for female subjects in blood was 2.5 h longer than that of the male subjects.
Compartments for Breath and Blood
Compartmental models traditionally associated each exponential function in the exhaled breath or blood concentration equation with time with a group of tissues. The compartments associated with half -lives from the breath for some VOCs have been reported as the blood, vessel -rich compartments, vessel -poor compartment and adipose tissue ( Raymer et al., 1991; Wallace et al., 1993) .
Typically, values of 3± 12 min for the first half -life have been reported . The half -lives calculated from this data set ( Table 11 ) for the breath second and blood first exponential function suggested that the second breath exponential function rather than the first breath exponential function is associated with a blood compartment.
One possible location for the very short breath half -life observed is in the lungs. The functional residual capacity (FRC ) is the volume of gas remaining in the lungs at the end of a normal tidal expiration. The FRC consists of the residual volume ( the volume of gas left in the lungs after a maximal forced expiration ) plus the expiratory reserve volume (Levitzky, 1986) . FRC could be the first compartment for the breath. Another possible compartment is mucous membranes in the oral and nasal passages. MTBE may be metabolized or retained in the upper airway before entering the human lung.
The disagreement of the half -lives of the breath third and blood second exponential function, representing a vessel tissue compartment, may have resulted from the limited number of observation at 2 h after exposures. The limited breath data will cause a high uncertainty for the curve fitting and the last half -life estimate, since only a single breath sample was collected after the time of the predicted half -life.
The third exponential function calculated for the blood data represents the vessel poor tissues or adipose tissues. A high uncertainty also exists in that estimate since it is based on only two data points and may be a composite of the halflives for two compartments (Raymer et al., 1991 ) .
Urinary Excretion
Urinary excretion of MTBE and unconjugated TBA represented a small portion of MTBE elimination as MTBE and unconjugated TBA compared to the amount exhaled. The background excretion rate for MTBE and unconjugated TBA were 0.3 ng/ min ( range, 0.11± 0.99 ng/ min ) and 0.5 ng /min (range, 0.09 ±1.3 ng /min ) . Following exposure, urinary MTBE was excreted quickly for the first 8 h with an excretion rate range of 0.7 ±6.9 ng /min. TBA excretion had a time lag relative to MTBE with an excretion rate range of 0.2 ±8 ng /min. Usually, the peak MTBE levels were observed in the first urine sample collected after exposure. The mean accumulated amounts (within 24 h of exposure ) of MTBE and TBA excreted in the urine were 1.4 and 2.3 g, which represented 0.95% and 1.85% of the internal dose, respectively.
The major routes of excretion of MTBE in rats were expired air and urine (Bio -Research Laboratories, 1990 ) . As the dose was increased, there was a shift in excretion with less being excreted in the urine and more being excreted in expired air. This shift has been attributed to saturation of metabolic pathways. In rats, small amounts of a TBA conjugate, likely a glucuronide, were present in the urine. 2 -Methyl -1,2-propanediol, 2-hydroxyisobutyrate and another unidentified conjugate of TBA were major urinary metabolites of MTBE. Conjugated TBA was not analyzed in this study. A molar balance of the human data, assuming an internal dose (absorbed dose ) following a 15 -min exposure to MTBE of 100 g, based on previous estimations, would result in 60± 70 g of MTBE being excreted through exhaled air and only 2± 3 g being excreted through urine as MTBE and unconjugated TBA in 24 h. This results in 27 ±38% of internal dose being unaccounted for. Further metabolites of TBA, hydroxyisobutyric acid and methyl propanediol, have been identified in human studies ( Amberg et al., 1999; Nihle Ân et al., 1999 ) .
Summary and conclusions
1. The overall mean of the fraction of air concentration exhaled during exposures for the six subjects was 0.33 0.06, with 69% of the absorbed doses were expired through respiration within 8 h following the 1.7 -ppm, 15 -min exposure to MTBE.
2. The ranges of MTBE half -lives for the first compartment, possibly in the lung, is 1 ±4 min; for the second compartment, presumably the blood, is 9 ± 53 min; for the third compartment, presumably vessel rich tissue, is 2 ±8 h; and a final compartment of vessel pore or adipose tissue is 14 ±24 h.
3. Blood MTBE reached its highest level right after exposure, whereas TBA reached its highest levels around 2 ±4 h after exposure and then declined slowly. A strong correlation between blood MTBE and breath MTBE was found with mean blood -to -breath ratio of 23.5.
4. Following the exposure, the MTBE urinary excretion rates increased immediately with the TBA excretion reached its highest levels around 6 ± 8 h later, returning to background levels around 20 h after exposure. Approximately 0.7 ±1.5% of the amount of MTBE inhaled was excreted unchanged as urinary MTBE, and 1 ±3% was excreted as urinary TBA within 24 h after exposure. 
